The Journal of thoracic and cardiovascular surgery
-
J. Thorac. Cardiovasc. Surg. · Mar 2022
Randomized Controlled Trial Multicenter Study Comparative StudyInfluence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting.
It remains unclear whether aggressive low-density lipoprotein cholesterol (LDL-C) management (<1.8 mmol/L) can slow the process of vein graft stenosis. This study aimed to explore the impact of baseline LDL-C levels on vein graft patency in patients on ticagrelor with or without aspirin 1 year after coronary artery bypass grafting (CABG). ⋯ In general, baseline LDL-C is not associated with 1-year vein graft patency after CABG. Regardless of the baseline LDL-C levels, ticagrelor + aspirin was superior to aspirin alone in maintaining vein graft patency. The primary factor causing early vein graft disease might not be atherosclerosis but thrombosis.
-
J. Thorac. Cardiovasc. Surg. · Mar 2022
Multicenter Study Comparative StudyCurrent practice patterns for use of the radial artery for coronary surgery in dedicated centers.
-
J. Thorac. Cardiovasc. Surg. · Mar 2022
Comparative Study Observational StudyMidterm outcomes and durability of sinus segment preservation compared with root replacement for acute type A aortic dissection.
The durability of root repair for acute type A aortic dissection is not well studied in the context of aortic insufficiency and stability of the sinuses of Valsalva. We compared clinical and functional outcomes in patients undergoing root repair and replacement for acute type A aortic dissection. ⋯ Survival is similar, but the incidence of aortic insufficiency and root dilation may be greater after root repair compared with root replacement for acute type A aortic dissection.